Hess Corp has a consensus price target of $162.95 based on the ratings of 22 analysts. The high is $210 issued by Mizuho on May 13, 2024. The low is $114 issued by Morgan Stanley on December 13, 2021. The 3 most-recent analyst ratings were released by Susquehanna, Bernstein, and Scotiabank on July 22, 2024, July 17, 2024, and July 12, 2024, respectively. With an average price target of $165 between Susquehanna, Bernstein, and Scotiabank, there's an implied 9.82% upside for Hess Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/22/2024 | Buy Now | 10.48% | Susquehanna | Biju Perincheril | $167 → $166 | Maintains | Neutral | Get Alert |
07/18/2024 | Buy Now | — | Wolfe Research | Doug Leggate | — | Reinstates | → Peer Perform | Get Alert |
07/17/2024 | Buy Now | 14.48% | Bernstein | Bob Brackett | $166 → $172 | Upgrade | Market Perform → Outperform | Get Alert |
07/12/2024 | Buy Now | 4.49% | Scotiabank | Paul Cheng | $165 → $157 | Maintains | Sector Perform | Get Alert |
06/05/2024 | Buy Now | 6.49% | Citigroup | Scott Gruber | $145 → $160 | Maintains | Neutral | Get Alert |
05/16/2024 | Buy Now | 11.15% | Susquehanna | Biju Perincheril | $164 → $167 | Maintains | Neutral | Get Alert |
05/13/2024 | Buy Now | 39.77% | Mizuho | Nitin Kumar | $205 → $210 | Maintains | Neutral | Get Alert |
04/22/2024 | Buy Now | 9.15% | Susquehanna | Biju Perincheril | $156 → $164 | Maintains | Neutral | Get Alert |
04/18/2024 | Buy Now | 15.14% | Piper Sandler | Ryan Todd | $172 → $173 | Maintains | Overweight | Get Alert |
03/20/2024 | Buy Now | 36.44% | Mizuho | Nitin Kumar | $200 → $205 | Maintains | Neutral | Get Alert |
03/14/2024 | Buy Now | 14.48% | Piper Sandler | Ryan Todd | $169 → $172 | Maintains | Overweight | Get Alert |
03/04/2024 | Buy Now | 3.83% | Susquehanna | Biju Perincheril | $152 → $156 | Maintains | Neutral | Get Alert |
02/26/2024 | Buy Now | 33.11% | Mizuho | Nitin Kumar | $170 → $200 | Maintains | Neutral | Get Alert |
01/26/2024 | Buy Now | 1.16% | Susquehanna | Biju Perincheril | $160 → $152 | Maintains | Neutral | Get Alert |
12/14/2023 | Buy Now | 29.78% | UBS | Josh Silverstein | $210 → $195 | Maintains | Buy | Get Alert |
11/07/2023 | Buy Now | 13.81% | Argus Research | Bill Selesky | → $171 | Upgrade | Hold → Buy | Get Alert |
11/02/2023 | Buy Now | 10.48% | Bernstein | Bob Brackett | $189 → $166 | Downgrade | Outperform → Market Perform | Get Alert |
10/26/2023 | Buy Now | 6.49% | Susquehanna | Biju Perincheril | $197 → $160 | Downgrade | Positive → Neutral | Get Alert |
10/24/2023 | Buy Now | 13.81% | Wells Fargo | Roger Read | $170 → $171 | Downgrade | Overweight → Equal-Weight | Get Alert |
10/24/2023 | Buy Now | — | Raymond James | John Freeman | — | Downgrade | Outperform → Market Perform | Get Alert |
10/18/2023 | Buy Now | 8.49% | Citigroup | Scott Gruber | $155 → $163 | Maintains | Neutral | Get Alert |
10/18/2023 | Buy Now | 31.11% | Susquehanna | Biju Perincheril | $187 → $197 | Maintains | Positive | Get Alert |
10/18/2023 | Buy Now | 28.45% | Raymond James | John Freeman | $166 → $193 | Maintains | Outperform | Get Alert |
10/17/2023 | Buy Now | 9.82% | Morgan Stanley | Devin McDermott | $166 → $165 | Maintains | Overweight | Get Alert |
10/09/2023 | Buy Now | 12.48% | Piper Sandler | Ryan Todd | $167 → $169 | Maintains | Overweight | Get Alert |
10/04/2023 | Buy Now | 39.77% | UBS | Josh Silverstein | $206 → $210 | Maintains | Buy | Get Alert |
10/02/2023 | Buy Now | 10.48% | Morgan Stanley | Devin McDermott | $158 → $166 | Maintains | Overweight | Get Alert |
09/18/2023 | Buy Now | 18.47% | Mizuho | Nitin Kumar | $175 → $178 | Maintains | Neutral | Get Alert |
08/18/2023 | Buy Now | 5.16% | Morgan Stanley | Devin McDermott | $154 → $158 | Maintains | Overweight | Get Alert |
08/17/2023 | Buy Now | 37.1% | UBS | Josh Silverstein | $168 → $206 | Maintains | Buy | Get Alert |
08/16/2023 | Buy Now | 16.47% | Mizuho | Nitin Kumar | $169 → $175 | Maintains | Neutral | Get Alert |
08/02/2023 | Buy Now | 3.16% | Citigroup | Scott Gruber | $152 → $155 | Maintains | Neutral | Get Alert |
07/24/2023 | Buy Now | 10.48% | Raymond James | John Freeman | $172 → $166 | Maintains | Outperform | Get Alert |
07/21/2023 | Buy Now | 21.8% | Susquehanna | Biju Perincheril | $185 → $183 | Maintains | Positive | Get Alert |
07/18/2023 | Buy Now | 2.5% | Morgan Stanley | Devin McDermott | $158 → $154 | Maintains | Overweight | Get Alert |
07/11/2023 | Buy Now | 1.16% | Citigroup | Scott Gruber | $159 → $152 | Maintains | Neutral | Get Alert |
06/13/2023 | Buy Now | 9.15% | Piper Sandler | Ryan Todd | $168 → $164 | Maintains | Overweight | Get Alert |
05/19/2023 | Buy Now | 11.81% | Mizuho | Nitin Kumar | $170 → $168 | Maintains | Neutral | Get Alert |
05/18/2023 | Buy Now | 11.81% | Piper Sandler | Ryan Todd | $167 → $168 | Maintains | Overweight | Get Alert |
05/15/2023 | Buy Now | 5.16% | Morgan Stanley | Devin McDermott | $156 → $158 | Maintains | Overweight | Get Alert |
04/28/2023 | Buy Now | 5.82% | Citigroup | Scott Gruber | $153 → $159 | Maintains | Neutral | Get Alert |
04/21/2023 | Buy Now | 14.48% | Raymond James | John Freeman | $170 → $172 | Maintains | Outperform | Get Alert |
04/20/2023 | Buy Now | 11.15% | Piper Sandler | Ryan Todd | $166 → $167 | Maintains | Overweight | Get Alert |
04/19/2023 | Buy Now | 22.46% | UBS | Josh Silverstein | → $184 | Assumes | → Buy | Get Alert |
04/13/2023 | Buy Now | 3.83% | Morgan Stanley | Devin McDermott | $139 → $156 | Maintains | Overweight | Get Alert |
04/05/2023 | Buy Now | 5.16% | JP Morgan | Arun Jayaram | $156 → $158 | Maintains | Overweight | Get Alert |
03/27/2023 | Buy Now | -7.49% | Morgan Stanley | Devin McDermott | $130 → $139 | Maintains | Overweight | Get Alert |
03/24/2023 | Buy Now | -10.82% | Goldman Sachs | Neil Mehta | $170 → $134 | Maintains | Neutral | Get Alert |
03/10/2023 | Buy Now | 13.14% | Mizuho | Nitin Kumar | $163 → $170 | Maintains | Neutral | Get Alert |
03/10/2023 | Buy Now | 13.14% | Raymond James | John Freeman | $175 → $170 | Maintains | Outperform | Get Alert |
01/27/2023 | Buy Now | 6.49% | Citigroup | Scott Gruber | $155 → $160 | Maintains | Neutral | Get Alert |
01/27/2023 | Buy Now | 13.14% | Goldman Sachs | Neil Mehta | $161 → $170 | Downgrade | Buy → Neutral | Get Alert |
01/26/2023 | Buy Now | 33.11% | B of A Securities | Doug Leggate | $185 → $200 | Maintains | Buy | Get Alert |
01/26/2023 | Buy Now | 13.14% | Wells Fargo | Roger Read | $162 → $170 | Maintains | Overweight | Get Alert |
01/26/2023 | Buy Now | -0.17% | Credit Suisse | William Janela | $125 → $150 | Maintains | Neutral | Get Alert |
01/25/2023 | Buy Now | 8.49% | Mizuho | Nitin Kumar | $164 → $163 | Maintains | Neutral | Get Alert |
01/23/2023 | Buy Now | 6.49% | Barclays | Jeanine Wai | $155 → $160 | Maintains | Overweight | Get Alert |
01/23/2023 | Buy Now | 16.47% | Raymond James | John Freeman | $160 → $175 | Maintains | Outperform | Get Alert |
01/19/2023 | Buy Now | -13.48% | Morgan Stanley | Devin McDermott | $123 → $130 | Maintains | Overweight | Get Alert |
01/12/2023 | Buy Now | 20.47% | Wolfe Research | Sam Margolin | → $181 | Upgrade | Peer Perform → Outperform | Get Alert |
01/10/2023 | Buy Now | 7.82% | Wells Fargo | Roger Read | $159 → $162 | Maintains | Overweight | Get Alert |
01/10/2023 | Buy Now | 9.15% | Mizuho | Nitin Kumar | $150 → $164 | Downgrade | Buy → Neutral | Get Alert |
12/19/2022 | Buy Now | 3.83% | Piper Sandler | Ryan Todd | $164 → $156 | Maintains | Overweight | Get Alert |
12/07/2022 | Buy Now | 3.16% | Barclays | Jeanine Wai | $145 → $155 | Maintains | Overweight | Get Alert |
11/11/2022 | Buy Now | 9.15% | Piper Sandler | Ryan Todd | $155 → $164 | Maintains | Overweight | Get Alert |
10/24/2022 | Buy Now | -0.17% | Mizuho | Vincent Lovaglio | $143 → $150 | Maintains | Buy | Get Alert |
10/19/2022 | Buy Now | -18.14% | Morgan Stanley | Devin McDermott | $134 → $123 | Maintains | Overweight | Get Alert |
10/19/2022 | Buy Now | -3.49% | Barclays | Jeanine Wai | $146 → $145 | Maintains | Overweight | Get Alert |
10/19/2022 | Buy Now | -6.82% | Jefferies | Lloyd Byrne | → $140 | Initiates | → Hold | Get Alert |
10/04/2022 | Buy Now | -2.83% | JP Morgan | Arun Jayaram | $149 → $146 | Maintains | Overweight | Get Alert |
09/21/2022 | Buy Now | -13.48% | Citigroup | Scott Gruber | $110 → $130 | Maintains | Neutral | Get Alert |
08/31/2022 | Buy Now | -2.83% | Barclays | Jeanine Wai | $149 → $146 | Maintains | Overweight | Get Alert |
08/31/2022 | Buy Now | -6.82% | Raymond James | John Freeman | $130 → $140 | Maintains | Outperform | Get Alert |
08/29/2022 | Buy Now | -10.82% | Morgan Stanley | Devin McDermott | $135 → $134 | Maintains | Overweight | Get Alert |
07/26/2022 | Buy Now | -13.48% | Raymond James | John Freeman | $140 → $130 | Maintains | Outperform | Get Alert |
07/19/2022 | Buy Now | -10.15% | Morgan Stanley | Devin McDermott | $141 → $135 | Maintains | Overweight | Get Alert |
07/19/2022 | Buy Now | 6.49% | B of A Securities | Doug Leggate | $180 → $160 | Maintains | Buy | Get Alert |
07/19/2022 | Buy Now | -4.83% | Mizuho | Vincent Lovaglio | $158 → $143 | Maintains | Buy | Get Alert |
07/19/2022 | Buy Now | 9.82% | Piper Sandler | Ryan Todd | $161 → $165 | Maintains | Overweight | Get Alert |
07/15/2022 | Buy Now | -0.83% | Barclays | Jeanine Wai | $153 → $149 | Maintains | Overweight | Get Alert |
06/24/2022 | Buy Now | — | Citigroup | Scott Gruber | — | Downgrade | Buy → Neutral | Get Alert |
06/14/2022 | Buy Now | 1.83% | Barclays | Jeanine Wai | $131 → $153 | Maintains | Overweight | Get Alert |
06/06/2022 | Buy Now | -6.16% | Morgan Stanley | Devin McDermott | $137 → $141 | Maintains | Overweight | Get Alert |
05/31/2022 | Buy Now | 5.16% | Mizuho | Vincent Lovaglio | $139 → $158 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | -10.15% | Wells Fargo | Roger Read | $133 → $135 | Maintains | Overweight | Get Alert |
04/25/2022 | Buy Now | -8.15% | Susquehanna | Biju Perincheril | $118 → $138 | Maintains | Positive | Get Alert |
04/25/2022 | Buy Now | -6.82% | Raymond James | John Freeman | $112 → $140 | Maintains | Outperform | Get Alert |
04/22/2022 | Buy Now | -8.82% | Morgan Stanley | Devin McDermott | $121 → $137 | Maintains | Overweight | Get Alert |
04/12/2022 | Buy Now | -12.81% | Barclays | Jeanine Wai | $124 → $131 | Maintains | Overweight | Get Alert |
03/31/2022 | Buy Now | -7.49% | Mizuho | Vincent Lovaglio | $132 → $139 | Maintains | Buy | Get Alert |
03/11/2022 | Buy Now | -11.48% | Wells Fargo | Roger Read | $106 → $133 | Maintains | Overweight | Get Alert |
01/27/2022 | Buy Now | -41.43% | Credit Suisse | William Janela | $86 → $88 | Maintains | Neutral | Get Alert |
01/25/2022 | Buy Now | -19.47% | Morgan Stanley | Devin McDermott | $114 → $121 | Maintains | Overweight | Get Alert |
01/11/2022 | Buy Now | -30.12% | Barclays | Jeanine Wai | $106 → $105 | Maintains | Overweight | Get Alert |
12/13/2021 | Buy Now | -24.13% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
11/30/2021 | Buy Now | -12.15% | Mizuho | Silvio Micheloto | — | Maintains | Buy | Get Alert |
11/19/2021 | Buy Now | -22.13% | Morgan Stanley | Devin McDermott | — | Maintains | Overweight | Get Alert |
10/26/2021 | Buy Now | -25.46% | Raymond James | John Freeman | — | Maintains | Outperform | Get Alert |
10/06/2021 | Buy Now | -23.46% | Morgan Stanley | Devin McDermott | — | Maintains | Overweight | Get Alert |
07/29/2021 | Buy Now | -44.09% | Credit Suisse | William Janela | — | Maintains | Neutral | Get Alert |
The latest price target for Hess (NYSE:HES) was reported by Susquehanna on July 22, 2024. The analyst firm set a price target for $166.00 expecting HES to rise to within 12 months (a possible 10.48% upside). 32 analyst firms have reported ratings in the last year.
The latest analyst rating for Hess (NYSE:HES) was provided by Susquehanna, and Hess maintained their neutral rating.
The last upgrade for Hess Corp happened on July 17, 2024 when Bernstein raised their price target to $172. Bernstein previously had a market perform for Hess Corp.
The last downgrade for Hess Corp happened on November 2, 2023 when Bernstein changed their price target from $189 to $166 for Hess Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hess, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hess was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
While ratings are subjective and will change, the latest Hess (HES) rating was a maintained with a price target of $167.00 to $166.00. The current price Hess (HES) is trading at is $150.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.